| ncRNA name | GNAQ siRNA |
| ncRNA Category | siRNA |
| Disease name | uveal melanoma (UM) |
| Species | Homo sapiens |
| Tissues/Cell_line | UM cell lines OCM1, OMM2.3 and 92.1 |
| Methods | siRNA transfection, qPCR, CCK-8 assay, Western blot, annexin-V and PI staining |
| Expression pattern | associated |
| Functional description | Combined treatment of siGNAQ and H101 inhibited the proliferation and activated the apoptosis of OMM2.3 and 92.1 cells by blocking the phosphorylation of MEK1/2 and increasing the phosphorylation of YAP. |
| PubMed ID | 30320917 |
| Year | 2019 |
| Title | The oncolytic virus H101 combined with GNAQ siRNA-mediated knockdown reduces uveal melanoma cell viability. |
| Drug-related ncRNA | NO |
Copyright © Institution of Biomedical Big Data, Wenzhou Medical University All rights reserved.